KINTOR Trademark

Trademark Overview


On Friday, May 21, 2021, a trademark application was filed for KINTOR with the United States Patent and Trademark Office. The USPTO has given the KINTOR trademark a serial number of 90726883. The federal status of this trademark filing is REGISTERED as of Tuesday, July 12, 2022. This trademark is owned by Kintor Pharmaceutical Limited. The KINTOR trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:

Medicines for treatment of cancer; sachets for pharmaceutical purposes, medicines in the form of capsules, chemico-pharmaceutical preparations, drugs for medical purposes, chemical preparations for pharmaceutical purposes, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external ...

Scientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO ...
kintor

General Information


Serial Number90726883
Word MarkKINTOR
Filing DateFriday, May 21, 2021
Status700 - REGISTERED
Status DateTuesday, July 12, 2022
Registration Number6785290
Registration DateTuesday, July 12, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 26, 2022

Trademark Statements


Goods and ServicesMedicines for treatment of cancer; sachets for pharmaceutical purposes, medicines in the form of capsules, chemico-pharmaceutical preparations, drugs for medical purposes, chemical preparations for pharmaceutical purposes, biological preparations for medical purposes, chemical preparations for medical purposes, all of the foregoing for the treatment of cancer; anti-cancer pharmaceutical preparations; pharmaceutical preparations for the diagnosis and treatment of cancer; pharmaceutical products for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; compounds for treating cancer; pharmaceuticals, medical and veterinary preparations for the prevention, diagnosis, treatment and adjunctive therapy of cancer, cardiovascular disease, nervous system diseases, infectious diseases, respiratory diseases, endocrine and metabolic diseases, mental disorder, skin disease, diseases of the blood system, digestive system diseases, immune system diseases, diseases of genitourinary system, ocular diseases, otolaryngology and dentistry diseases, musculoskeletal and connective tissue diseases, nutritional diseases, diseases caused by external factors, namely, poisoning and injury; sanitary preparations for medical purposes; dietetic food and substances, namely, dietetic foods, sugar substitutes, nutritional beverages, and dietary supplements for weight loss adapted for medical and veterinary use; food for babies; dietary supplements for humans and animals; plasters and materials, namely, gauze for medical dressings; materials for dental fillings and for sealing purposes; dental wax; disinfectants; preparations for destroying vermin; fungicides; herbicides; pharmaceutical preparations for the prevention, diagnosis, treatment and adjunctive therapy of coronaviruses, Covid-19, influenza viruses, influenza A, influenza B, SARS-CoV-1, SARSCoV-2, MERS-CoV, and rhinoviruses
Goods and ServicesScientific and medical research services; pharmaceutical research services; research relating to pharmaceuticals; research and development of pharmaceutical products; biotechnology research; biochemistry and chemical research services; scientific research relating to biology and chemistry; scientific research in the field of pharmacy; scientific research into the development of new products; testing services for assessing the efficacy and safety of pharmaceuticals; preparation of reports relating to scientific research; analytical medical and scientific laboratory services; medical and scientific laboratory research and analysis; development of products; development of pharmaceutical preparations for the diagnosis and treatment of cancer; advisory services relating to scientific research; scientific and technological services in the field of pharmaceuticals and research and design relating thereto, namely, consulting and advisory services, CRO (Contract Research Organization) and CDMO (Contract Development and Manufacturing Organization) services; industrial analysis and research services in the field of pharmaceuticals; design and development of computer hardware and software; information, advisory and consultancy services relating to all the aforesaid services

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2021
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 18, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameKintor Pharmaceutical Limited
Party Type30 - Original Registrant
Legal Entity Type99 - Other
AddressSuzhou 215123
CN

Party NameKintor Pharmaceutical Limited
Party Type20 - Owner at Publication
Legal Entity Type99 - Other
AddressSuzhou 215123
CN

Party NameKintor Pharmaceutical Limited
Party Type10 - Original Applicant
Legal Entity Type99 - Other
AddressSuzhou 215123
CN

Trademark Events


Event DateEvent Description
Tuesday, July 12, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, July 12, 2022REGISTERED-PRINCIPAL REGISTER
Wednesday, May 4, 2022CHANGES/CORRECTIONS AFTER PUB APPROVAL ENTERED
Tuesday, April 26, 2022WITHDRAWN FROM ISSUE - PETITIONS OFFICE REQUEST
Tuesday, April 26, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 26, 2022PUBLISHED FOR OPPOSITION
Tuesday, April 19, 2022ASSIGNED TO PETITION STAFF
Thursday, April 7, 2022TEAS POST PUBLICATION AMENDMENT RECEIVED
Wednesday, April 6, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 23, 2022LAW OFFICE PUBLICATION REVIEW COMPLETED
Tuesday, March 22, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 15, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Tuesday, March 15, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, March 14, 2022ASSIGNED TO LIE
Saturday, March 12, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, February 20, 2022APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Sunday, February 20, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Sunday, February 20, 2022TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
Sunday, February 20, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Sunday, February 20, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Sunday, February 20, 2022TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, December 28, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, December 28, 2021NON-FINAL ACTION E-MAILED
Tuesday, December 28, 2021NON-FINAL ACTION WRITTEN
Wednesday, December 22, 2021ASSIGNED TO EXAMINER
Wednesday, August 18, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Tuesday, May 25, 2021NEW APPLICATION ENTERED IN TRAM